Methotrexate and misoprostol for early abortion in adolescent women

Journal of Pediatric and Adolescent Gynecology

Volumn 12, Issue 2, 1999, Pages 71-77

  Creinin, M D ^a   Wiebe, E ^b   Gold, M ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Abortion; Abortion, medical; Methotrexate; Misoprostol; Prostaglandins

Indexed keywords

ABORTIVE AGENT; METHOTREXATE; MISOPROSTOL;

ADOLESCENT; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HEADACHE; HOME CARE; HUMAN; INDUCED ABORTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LETHARGY; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; PATIENT COUNSELING; PATIENT SATISFACTION; PRIORITY JOURNAL; SOCIAL SUPPORT; VERTIGO; VOMITING;

EID: 0033133370     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-3188(00)86630-9     Document Type: Article

References (18)

1. Creinin MD, Vittinghoff E, Keder L, et al: Methotrexate and misoprostol for early abortion: A multicenter trial. I. Safety and efficacy. Contraception 1996; 53:321
2. Creinin MD, Vittinghoff E, Schaff E, et al: Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997; 90:611
3. Creinin MD, Park M: Acceptability of abortion with methotrexate and misoprostol. Contraception 1995; 52:41
4. Creinin MD, Burke AE: Methotrexate and misoprostol for early abortion: A multicenter trial. Acceptability. Contraception 1996; 54:19
5. Centers for Disease Control and Prevention: State-specific birth rates for teenagers - United States, 1990-1996. MMWR Morb Mortal Wkly Rep 1997; 46:837
6. Piccinino LJ: Unintended pregnancy and childbearing in the United States: 1973-1995. In: Advance Data from Vital and Health Statistics. Hyattsville, MD: United States Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics (in press)
7. Abma JC, Chandra A, Mosher WD, et al: Fertility, Family Planning, and Women's Health: New Data from the 1995 National Survey of Family Growth. Hyattsville, MD: United States Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, 1997
8. Koonin LM, Smith JC, Ramick M, et al: Abortion surveillance: United States, 1993 and 1994. MMWR CDC Surveill Summ 1997; 46(SS-4):37
9. McCord ML, Muram D, Lipscomb GH, et al: Methotrexate therapy for ectopic pregnancy in adolescents. J Pediatr Adolesc Gynecol 1996; 9:71
10. Rossavik IK, Torjusen GO, Gibbons WE: Conceptual age and ultrasound measurements of gestational sac and crown-rump length in in vitro fertilization pregnancies. Fertil Steril 1988; 49:1012
11. Goldstein SR, Wolfson R: Endovaginal ultrasonographic measurement of early embryonic size as a means of assessing gestational age. J Ultrasound Med 1994; 13:27
12. Creinin MD: Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996; 54:15
13. Creinin MD, Darney PD: Methotrexate and misoprostol for early abortion. Contraception 1993; 48:339
14. Creinin MD, Vittinghoff E, Galbraith S, et al: Methotrexate and misoprostol for early abortion: A randomized trial comparing misoprostol 3 days and 7 days following methotrexate. Am J Obstet Gynecol 1995; 173:1578
15. DiSaia PJ, Creasman WT (eds): Clinical Gynecologic Oncology. St. Louis: Mosby, 1989:378
16. Tang GW, Lau OWK, YiP P: Further acceptability evaluation of RU 486 and ONO 802 as abortifacient agents in a Chinese population. Contraception 1993; 48:267
17. Winikoff B, Ellertson C, Elul B, et al: Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: Results of a large multi-center trial in the United States. Arch Fam Med 1998; 7:360
18. Creinin MD: A reassessment of efficacy of the Yuzpe regimen of emergency contraception. Hum Reprod 1997; 12:101